BioCardia (NASDAQ:BCDA) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of BioCardia (NASDAQ:BCDA – Free Report) in a report issued on Tuesday morning, Benzinga reports. The brokerage...
StockNews.com Begins Coverage on Tenax Therapeutics (NASDAQ:TENX)
StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report published on Tuesday. The brokerage issued a sell rating on...
JMP Securities Trims Viridian Therapeutics (NASDAQ:VRDN) Target Price to $38.00
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price target trimmed by JMP Securities from $42.00 to $38.00 in a research note released on Tuesday,...
Wedbush Reaffirms Outperform Rating for Sutro Biopharma (NASDAQ:STRO)
Wedbush restated their outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a report released on Tuesday, RTT News reports. They currently...
2seventy bio (NASDAQ:TSVT) Earns “Outperform” Rating from Wedbush
Wedbush reissued their outperform rating on shares of 2seventy bio (NASDAQ:TSVT – Free Report) in a research note published on Tuesday, RTT News reports. The...
HC Wainwright Trims Aclaris Therapeutics (NASDAQ:ACRS) Target Price to $9.00
Aclaris Therapeutics (NASDAQ:ACRS – Free Report) had its target price decreased by HC Wainwright from $43.00 to $9.00 in a research report sent to investors...